Literature DB >> 839842

Histology of bronchial carcinoma and regional lymph nodes as putative immune response of the host to the tumor.

M Di Paola, A Bertolotti, S Colizza, M Coli.   

Abstract

Two hundred forty-two patients who had bronchial carcinoma and who underwent radical surgery were studied in order to determine putative host resistance to the tumor at histologic level, i.e., lymphocytic infiltration in the center and around the tumor, together with sinus histiocytosis and follicular hyperplasia in the regional lymph nodes. These features were evaluated in a semiquantitative way, giving rise to three groups of patients: D- (reaction absent or poor), D+ (reaction present), and D++ (strong reaction present). Five-year survival rates and the incidence of metastases in regional nodes were significantly related to the putative host resistance against the tumor, but no clear-cut correlation between grade of malignancy of the tumor and histologic type was evidenced. The significance of these reactive changes is fully discussed.

Entities:  

Mesh:

Year:  1977        PMID: 839842

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Morphological predictors of survival in early and advanced gastric carcinoma.

Authors:  P Schmitz-Moormann; P Hermanek; G W Himmelmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Tumour volume and macroscopic growth pattern of bronchogenic carcinoma.

Authors:  K Kayser; H Toomes; H H Vollhaber; H U Burkhardt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.

Authors:  O Eremin; P Roberts; D Plumb; J P Stephens
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

4.  EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.

Authors:  T Suzuki; S Inoue; W Kawabata; J Akahira; T Moriya; F Tsuchiya; S Ogawa; M Muramatsu; H Sasano
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

5.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct

6.  Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance.

Authors:  H M Anthony; C J Schorah
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

7.  Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.

Authors:  J-I Akahira; M Aoki; T Suzuki; T Moriya; H Niikura; K Ito; S Inoue; K Okamura; H Sasano; N Yaegashi
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.